Stereotactic Body Radiation Therapy Versus Intensity-Modulated Radiation Therapy for Prostate Cancer: Less Cost at the Expense of More Genitourinary Toxicity Is a Concerning But Testable Hypothesis
Author:
- 20 April 2014
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 32 (12) , 1183-1185
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Prostate cancer, version 1.2014.Journal of the National Comprehensive Cancer Network, 2013
- Overdiagnosis and Overtreatment in CancerJAMA, 2013
- Initial management of prostate‐specific antigen‐detected, low‐risk prostate cancer and the risk of death from prostate cancerBJU International, 2013
- Radical Prostatectomy versus Observation for Localized Prostate CancerNew England Journal of Medicine, 2012
- Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development studyThe Lancet Oncology, 2012
- Comorbidity and Mortality Results From a Randomized Prostate Cancer Screening TrialJournal of Clinical Oncology, 2011
- Mortality results from the Göteborg randomised population-based prostate-cancer screening trialThe Lancet Oncology, 2010
- Testing the most stringent criteria for selection of candidates for active surveillance in patients with low‐risk prostate cancerBJU International, 2010
- Mortality Results from a Randomized Prostate-Cancer Screening TrialNew England Journal of Medicine, 2009
- Screening and Prostate-Cancer Mortality in a Randomized European StudyNew England Journal of Medicine, 2009